Skip to content

Edel Maex

Active
Private limited company· 5 yrs active
Keizershoevestraat 18 ·2610 Antwerpen, Belgium
BE 0769.870.786
Watch Print / PDF
Age5 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Edel Maex is 2.5% (moderate). The 2024 annual accounts show equity of €195k and a net result of €52k. Equity is growing by ~37% per year across the filed fiscal years. The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Trust signals

3 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
2.5% Moderate
0%0,5%1,5%4%10%≥25%
Young company +No NACE activity registered +Annual accounts: healthy financial profile

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€52k-6.0%
Working capital€195k+35.8%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 31-07-2025 with the NBB · fiscal year 2024 · micro
€0€50k€100k€150kOperating result 2022: €131k€131kNet result 2022: €89k€89kOperating result 2023: €80k€80kNet result 2023: €55k€55kOperating result 2024: €76k€76kNet result 2024: €52k€52k202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~37%/year over 3 fiscal years, indicative, assuming unchanged policy.
€0€100k€200k€300k€400k2025: €249k (€233k - €264k)2026: €302k (€286k - €317k)2027: €355k (€339k - €370k)2022: €89k2023: €144k2024: €195k202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Net profit
€52k
-6.0% 22-24
Total assets
€233k
-1.7% 22-24
Equity
€195k
+35.8% 22-24
Working capital
€195k
+35.8% 22-24
Income taxes
€24k
-5.9% 22-24
Debt
€38k
-59.4% 22-24
Debt ≤ 1y
€38k
-59.4% 22-24
Current ratio
6.14
+141.9% 22-24
Quick ratio
6.14
+141.9% 22-24
Solvency
83.7%
+38.2% 22-24
Debt / equity
0.19
-70.1% 22-24
ROE
26.4%
-30.8% 22-24
ROA
22.1%
-4.3% 22-24
Figures by fiscal year
Fiscal year2024
Revenue-
EBITDA-
Net profit€52k
Cash flow-
Staff costs-
Income taxes€24k
Dividends-
Total assets€233k
Equity€195k
Debt€38k
of which ≤ 1y€38k
of which > 1y-
Working capital€195k
Employees (FTE)-
Ratios (computed)
2024
Current ratio6.14
Quick ratio6.14
Working capital ratio83.7%
Solvency83.7%
Debt / equity0.19
Long-term debt ratio-
Interest coverage-
Gross margin-
Net margin-
ROA22.1%
ROE26.4%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€233k
Current assets 29/58€233k
Amounts receivable within one year 40/41€8k
Cash & bank 54/58€225k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€233k
Equity 10/15€195k
Contributions / capital 10/11€100
Reserves 13€195k
Amounts payable 17/49€38k
Amounts payable within one year 42/48€38k
Trade debts payable within one year 44€1k
Income statement
Gross operating margin 9900€76k
Operating result 9901€76k
Result before taxes 9903€76k
Income taxes 67/77€24k
Net result for the period 9904€52k
Result to be appropriated 9905€52k
You're seeing the latest fiscal year only. Unlock 2 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
85 / 100 Excellent
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Structure & network

Locations & real estate

Establishment units

1 location
Edel Maex
Keizershoevestraat 18, 2610 AntwerpenActiviteiten van medisch specialisten
since 20212.318.576.350
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area286 m²
Buildings1
Building footprint111 m²

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11051B0373/00H003 Flanders 286 m² 1 · 111 m² -
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Analysis

Snowflake analysis

financial profile on 5 axes
Health85Profitability100Solvency100Growth52Stability94
86 / 100

Exceptional profile, strong across almost every axis.

Health 85
Profitability 100
Solvency 100
Growth 52
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Company registry

Company registry (CBE)

Crossroads Bank
Names & trade names
Legal nameNL Edel Maex
Registered office
Keizershoevestraat 18
2610 Antwerpen, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.